| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/13/2001 | CA2079230C Bcrf1 antagonists for treating epstein-barr virus infections |
| 02/13/2001 | CA2067653C Modified complement system regulator |
| 02/13/2001 | CA2067334C Recombinant production of lactoperoxidase |
| 02/13/2001 | CA2067224C Hirudin/polyalkylene glycol conjugates |
| 02/13/2001 | CA2055506C Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars |
| 02/13/2001 | CA2048619C Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
| 02/13/2001 | CA2021788C Cyclosporin derivatives |
| 02/13/2001 | CA2004202C Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
| 02/10/2001 | WO2001032871A2 Follistatin-related protein zfsta4 |
| 02/10/2001 | CA2389956A1 Follistatin-related protein zfsta4 |
| 02/09/2001 | CA2315594A1 Process for the preparation of aqueous formulations for ophthalmic use |
| 02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 02/08/2001 | WO2001009616A2 Method for determining physiological effects of hemoglobin |
| 02/08/2001 | WO2001009390A1 Tenascin-c nucleic acid ligands |
| 02/08/2001 | WO2001009379A1 Antisense modulation of pepck-mitochondrial expression |
| 02/08/2001 | WO2001009368A1 Follistatin antagonists |
| 02/08/2001 | WO2001009360A1 USE OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR (rAAV) FOR THE PREVENTION OF SMOOTH MUSCLE CELL PROLIFERATION IN A VASCULAR GRAFT |
| 02/08/2001 | WO2001009349A1 Gene encoding novel serine protease-like protein |
| 02/08/2001 | WO2001009346A1 Gene encoding novel adenylate kinase 3 (ak3)-like protein |
| 02/08/2001 | WO2001009345A1 Novel genes encoding protein kinase/protein phosphatase |
| 02/08/2001 | WO2001009341A2 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 02/08/2001 | WO2001009334A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 02/08/2001 | WO2001009327A2 Method of preventing the injury or death of retinal cells and treating ocular diseases |
| 02/08/2001 | WO2001009325A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | WO2001009323A1 Guanosine triphosphate binding protein-coupled receptors, genes thereof and production and use of the same |
| 02/08/2001 | WO2001009322A1 Guanosine triphosphate-binding protein coupled receptors, genes thereof and production and use of the same |
| 02/08/2001 | WO2001009321A1 Gene encoding novel tsp1-like protein |
| 02/08/2001 | WO2001009320A1 Gene encoding novel adp-ribosylation factor (arf)-like protein |
| 02/08/2001 | WO2001009319A1 Gene expressed specifically in human fetal heart muscle |
| 02/08/2001 | WO2001009318A1 Liver cancer-associated genes |
| 02/08/2001 | WO2001009317A1 Stomach cancer-associated gene |
| 02/08/2001 | WO2001009316A1 Novel genes encoding protein kinase/protein phosphatase |
| 02/08/2001 | WO2001009315A1 Novel gene participating in the maintenance of smooth muscle cell differentiation |
| 02/08/2001 | WO2001009297A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 02/08/2001 | WO2001009294A1 Antifungic compositions and method for controlling fungi |
| 02/08/2001 | WO2001009293A2 Mammalian adhesion protease peptides |
| 02/08/2001 | WO2001009194A1 Recombinant proteins and molecular complexes derived therefrom, analogous to molecules involved in immune responses |
| 02/08/2001 | WO2001009189A2 Compositions and methods for the treatment of tumors |
| 02/08/2001 | WO2001009188A1 Binding moieties for fibrin |
| 02/08/2001 | WO2001009186A2 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 02/08/2001 | WO2001009185A2 Transmembrane transport proteins, nucleic acids encoding them and uses therefor |
| 02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |
| 02/08/2001 | WO2001009183A2 Polymorphisms in the human mdr-1 gene and applications thereof |
| 02/08/2001 | WO2001009182A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 02/08/2001 | WO2001009178A2 Human chaperone proteins |
| 02/08/2001 | WO2001009174A2 Plant defensin variants |
| 02/08/2001 | WO2001009173A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | WO2001009171A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 02/08/2001 | WO2001009170A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/08/2001 | WO2001009169A2 Cysteine protease inhibitors |
| 02/08/2001 | WO2001009167A1 KdtB |
| 02/08/2001 | WO2001009163A2 Improvement of peptide transport by conjugation with bile acids |
| 02/08/2001 | WO2001009162A2 Secreted proteins and uses thereof |
| 02/08/2001 | WO2001009159A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 02/08/2001 | WO2001009157A1 High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors |
| 02/08/2001 | WO2001009156A1 HIGH AFFINITY TGFη NUCLEIC ACID LIGANDS AND INHIBITORS |
| 02/08/2001 | WO2001009116A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)- 2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 02/08/2001 | WO2001009115A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
| 02/08/2001 | WO2001009097A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 02/08/2001 | WO2001009000A1 A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids |
| 02/08/2001 | WO2001008720A2 Hypocretin and hypocretin receptors in regulation of sleep and related disorders |
| 02/08/2001 | WO2001008717A1 Controlled release implantable devices |
| 02/08/2001 | WO2001008709A1 Sonoporation of tumors |
| 02/08/2001 | WO2001008708A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 02/08/2001 | WO2001008707A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 02/08/2001 | WO2001008700A1 Preventing immune-mediated abortion by inhibiting costimulation |
| 02/08/2001 | WO2001008699A1 Methods of inhibiting osteoclastogenesis |
| 02/08/2001 | WO2001008698A1 Activity potentiators for chemotherapeutics, anticancer compositions and method for potentiating the activity of chemotherapeutics |
| 02/08/2001 | WO2001008697A2 Use of stanniocalcin 2 in the treatment of type ii diabetes and complications thereof |
| 02/08/2001 | WO2001008696A2 Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy |
| 02/08/2001 | WO2001008695A2 Use of amh and/or amh agonists and/or amh antagonists for long-term control of female fertility |
| 02/08/2001 | WO2001008694A2 Direct arterial infiltration for production of vascular pathology |
| 02/08/2001 | WO2001008691A1 Methods for transdifferentiation of body tissues |
| 02/08/2001 | WO2001008684A1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 02/08/2001 | WO2001008677A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | WO2001008635A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
| 02/08/2001 | WO2001008609A1 Method and article to induce hematopoietic expansion |
| 02/08/2001 | WO2001008486A1 CoaA POLYPEPTIDES AND POLYNUCLEOTIDES AND METHODS THEREOF |
| 02/08/2001 | WO2000075317A3 Compositions and methods for the treatment of tumor |
| 02/08/2001 | WO2000075310A8 Interleukin-1-receptor associated kinase-3 (irak3) |
| 02/08/2001 | WO2000070017A3 Methods using of fab i and compounds modulating fab i activity |
| 02/08/2001 | WO2000069894A3 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 02/08/2001 | WO2000069456A3 Adjuvant combination formulations |
| 02/08/2001 | WO2000069449A3 Conditioned cell culture medium compositions and methods of use |
| 02/08/2001 | WO2000067774A3 Materials for soft tissue augmentation and methods of making and using same |
| 02/08/2001 | WO2000067769A8 Enhanced survival of cancer patients treated with erythropoietin and antitumor agents |
| 02/08/2001 | WO2000067700A3 Recombinant vaccine against botulinum neurotoxin |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 02/08/2001 | WO2000066141A3 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy |
| 02/08/2001 | WO2000064485A8 Specifically targeted catalytic antagonists and uses thereof |
| 02/08/2001 | WO2000064464A8 NUCLEIC ACIDS AND PROTEINS OF A RAT GANGLIOSIDE GM1-SPECIFIC αl→2FUCOSYLTRANSFERASE AND USES THEREOF |
| 02/08/2001 | WO2000064460A3 Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin |
| 02/08/2001 | WO2000063247A3 Osteopontin-derived chemotactic and inhibitory agents and uses therefor |
| 02/08/2001 | WO2000063230A3 49 human secreted proteins |
| 02/08/2001 | WO2000061772A3 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/08/2001 | WO2000061756A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 02/08/2001 | WO2000059525A3 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 02/08/2001 | WO2000053773A3 Methods for mitochondrial gene therapy |